1. Home
  2. KGS vs PCVX Comparison

KGS vs PCVX Comparison

Compare KGS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kodiak Gas Services Inc.

KGS

Kodiak Gas Services Inc.

N/A

Current Price

$44.42

Market Cap

5.9B

Sector

N/A

ML Signal

N/A

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

N/A

Current Price

$60.89

Market Cap

7.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KGS
PCVX
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
7.0B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
KGS
PCVX
Price
$44.42
$60.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
11
Target Price
$79.50
★ $117.30
AVG Volume (30 Days)
1.7M
★ 3.7M
Earning Date
11-09-2026
11-13-2026
Dividend Yield
★ 4.18%
N/A
EPS Growth
★ 58.93
N/A
EPS
★ 0.75
N/A
Revenue
N/A
N/A
Revenue This Year
$16.18
N/A
Revenue Next Year
$14.49
N/A
P/E Ratio
$62.37
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.55
$39.87
52 Week High
$77.68
$90.75

Technical Indicators

Market Signals
Indicator
KGS
PCVX
Relative Strength Index (RSI) 35.16 46.07
Support Level $43.50 $58.85
Resistance Level $49.65 $63.08
Average True Range (ATR) 2.37 2.87
MACD 0.15 -0.55
Stochastic Oscillator 18.99 15.18

Price Performance

Historical Comparison
KGS
PCVX

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. The company manages its business through two operating segments: Contract Services and Other Services. Contract Services consists of operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings. Maximum revenue for the company is generated from its Contract Services segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: